Listening to the patient voice: Why developing new dementia treatments is everyone’s jobDeveloping life-changing treatments for dementia is a team effort that takes commitment from all involved, from charities and Share XListening to the patient voice: Why developing new dementia treatments is everyone’s jobhttps://pharmaphorum.com/views-and-analysis/listening-to-the-patient-voice-why-developing-new-dementia-treatments-is-everyones-job/
Sharing success to unlock the “triple win” of joint workingThe fortunes of the NHS and the UK’s life sciences industry are intertwined, with each sector’s success or Share XSharing success to unlock the “triple win” of joint workinghttps://pharmaphorum.com/r-d/views-analysis-r-d/sharing-success-to-unlock-the-triple-win-of-joint-working/
Time to build evidence for patient involvement in researchPatient and public involvement (PPI) may be increasingly seen as the “right thing to do”, but without systematic Share XTime to build evidence for patient involvement in researchhttps://pharmaphorum.com/views-analysis-patients/time-to-build-evidence-for-patient-involvement-in-research/
Making patient involvement meaningfulTrue public and patient involvement in research needs to be more than just a box ticking exercise – Share XMaking patient involvement meaningfulhttps://pharmaphorum.com/views-analysis-patients/making-patient-involvement-meaningful/
Digital health isn’t about big data – it’s about peopleFrom training a new generation of data scientists to overcoming privacy concerns, there’s a lot that needs to Share XDigital health isn’t about big data – it’s about peoplehttps://pharmaphorum.com/views-analysis-digital/digital-health-isnt-about-big-data-its-about-people/
Working together to embed public involvement in researchAmanda Barrell speaks to the ABPI deputy chief scientific officer Sheuli Porkess and the NIHR’s Simon Denegri at the Share XWorking together to embed public involvement in researchhttps://pharmaphorum.com/views-analysis-patients/abpi-working-together-to-embed-public-involvement-in-research/
Living with LHON: Sight loss won’t stop James from seeing the worldWhen he was first told he had LHON, a rare genetic disease that would rob him of his Share XLiving with LHON: Sight loss won’t stop James from seeing the worldhttps://pharmaphorum.com/views-analysis-patients/living-with-lhon-sight-loss-wont-stop-james-from-seeing-the-world/
Embracing next generation patient centricityPharma has largely accepted the value and importance of patient centricity – now it’s time to scale it Share XEmbracing next generation patient centricityhttps://pharmaphorum.com/patients/embracing-next-generation-patient-centricity/
Addressing MS’ two-tier healthcare system is about ‘social justice’NICE has reversed its decision not to approve a new drug that offers hope to thousands of people Share XAddressing MS’ two-tier healthcare system is about ‘social justice’https://pharmaphorum.com/views-analysis-patients/ms-two-tier-healthcare-system/
